GW Pharma Posts CBD Drug for Epilepsy Sales of Million in Q3

GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Third Quarter Ended September 30, 2019 Epidiolex U.S. year to date net sales of $188.0 million, including Q3 net sales of $86.1 million Conference call today at 4:30 p.m. ET CARLSBAD, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ: GWPH, GW, […] READ MORE: https://www.newcannabisventures.com/gw-pharma-posts-cbd-drug-for-epilepsy-sales-of-86-million-in-q3/ The post GW Pharma Posts CBD Drug for Epilepsy Sales of $86 Million in Q3 appeared first on Cannabis Daily.

Excerpt only …
READ MORE BELOW
Source : New feed
Link to original : GW Pharma Posts CBD Drug for Epilepsy Sales of Million in Q3
reposted by Cannabis News World